| http://www.w3.org/ns/prov#value | - We intend to leverage the expertise of ImmunoTox into expanded service offerings for our current customers including for the first time, flow cytometry, said AIBioTech president and chief scientific officer Robert B. Harris, Ph.D. The ability to monitor the immune response of the host organism is a critical component along the path of drug (and chemical) development, and by adding these service
|
